These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 61146)

  • 21. [Detection and significance of HBsAg associated receptors for polymerized human serum albumin in acute hepatitis B virus infection].
    Gerken G; Manns M; Hess G; Slusarczyk J; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1986 Feb; 24(2):93-9. PubMed ID: 3008456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoassay detection of IgM antibodies to the hepatitis B core antigen in HBsAg liver disease.
    Lavarini C; Crivelli O; Smedile A; Farci P; Marinucci G; Muglia M; Rizzetto M
    Boll Ist Sieroter Milan; 1982; 61(3):210-7. PubMed ID: 6985422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody to hepatitis B core antigen in chronic hepatitis and primary biliary cirrhosis: evaluation by a new autologous solid phase radioimmunoassay.
    Grady GF; Kaplan MM; Vyas GN
    Gastroenterology; 1977 Apr; 72(4 Pt 1):590-3. PubMed ID: 838211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus carrier with low titer of antibody to hepatitis B core antigen.
    Naito M; Matsuda H; Okuno H; Kim H; Azuma M; Kashiwagi T; Mitsutani N; Koizumi T; Kawaguchi G; Kobayashi Y
    Hepatogastroenterology; 1994 Jun; 41(3):235-8. PubMed ID: 7959545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune response in fulminant viral hepatitis, type B.
    Tabor E; Gerety RJ; Hoofnagle JH; Barker LF
    Gastroenterology; 1976 Oct; 71(4):635-40. PubMed ID: 60267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus-like particles in Australia antigen-associated hepatitis. An immunoelectron microscopic study of human liver.
    Huang SN; Millman I; O'Connell A; Aronoff A; Gault H; Blumberg BS
    Am J Pathol; 1972 Jun; 67(3):453-70. PubMed ID: 4113490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Circulating immune complexes in acute viral hepatitis, chronic active hepatitis, and periarteritis nodosa (author's transl)].
    Hütteroth TH; Arnold W; Hopf U; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1978 Jun; 16(6):395-402. PubMed ID: 27909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases.
    Michalak T
    Am J Pathol; 1978 Mar; 90(3):619-32. PubMed ID: 24342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymptomatic structural liver disease in hemophilia.
    Spero JA; Lewis JH; Van Theil DH; Hasiba U; Rabin BS
    N Engl J Med; 1978 Jun; 298(25):1373-8. PubMed ID: 349386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneoscopic liver biopsy findings in asymptomatic chronic HBsAg carriers with normal liver function tests and no hepatomegaly.
    Chon CY; Han KH; Lee KS; Moon YM; Kang JK; Park IS; Park C
    Yonsei Med J; 1996 Oct; 37(5):295-301. PubMed ID: 8997161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis.
    Alberti A; Realdi G; Tremolada F; Spina GP
    Clin Exp Immunol; 1976 Sep; 25(3):396-402. PubMed ID: 786518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic infections. Part I. A serological evaluation of Fab antigens (Fab' and F (ab)2) and antibodies in patients and asymptomatic carriers of hepatitis B virus.
    Vos GH; Marimuthu T; Vos D
    S Afr Med J; 1979 Nov; 56(19):751-56. PubMed ID: 505209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers.
    Sampliner RE; Hamilton FA; Iseri OA; Tabor E; Boitnott J
    Am J Med Sci; 1979; 277(1):17-22. PubMed ID: 425995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers.
    Beutner KR; Tiku ML; Ogra PL
    Infect Immun; 1978 Aug; 21(2):480-8. PubMed ID: 80380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of HBSAG in cerebrospinal fluid by means of a radioimmunoassay technique (author's transl)].
    Baumann W; Emmrich P; Arndt-Hanser A; Pyka R
    Immun Infekt; 1976 Feb; 4(1):29-32. PubMed ID: 1254317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.
    Eleftheriou N; Thomas HC; Heathcote J; Sherlock S
    Lancet; 1975 Dec; 2(7946):1171-3. PubMed ID: 53657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases.
    Arnold W; Hess G; Purcell RH; Kaplan PM; Gerin JL; Meyer KH
    Klin Wochenschr; 1978 Mar; 56(6):297-303. PubMed ID: 642401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen.
    Neurath AR; Trepo C; Chen M; Prince AM
    J Gen Virol; 1976 Mar; 30(3):277-85. PubMed ID: 56422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The e antigen and antibody in the serum of patients with HBsAg-positive liver disease and in asymptomatic carriers.
    Bonino F; Pinna G; Recchia S; Rizzetto M
    Ric Clin Lab; 1976; 6(3):251-7. PubMed ID: 1025647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.